Arkadios Wealth Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Sell
2,802
-453
-14% -$38.5K ﹤0.01% 1573
2026
Q1
$280K Buy
3,255
+312
+11% +$28K ﹤0.01% 1392
2025
Q4
$257K Buy
+2,943
New +$223K 0.01% 1318
2021
Q4
Sell
-54
Closed -$4K 1058
2021
Q3
$4K Buy
+54
New +$4.34K ﹤0.01% 1649
2021
Q1
Sell
-332
Closed -$21K 1680
2020
Q4
$21K Buy
+332
New +$19.1K ﹤0.01% 738
2020
Q2
Sell
-147
Closed -$6.25K 1022
2020
Q1
$6.25K Hold
147
﹤0.01% 739
2019
Q4
$8.31K Buy
+147
New +$7.98K 0.01% 624

Other funds holding GMED

Arkadios Wealth Advisors's GMED Position: Q2 2026 in Review

Arkadios Wealth Advisors reduced its Globus Medical (GMED) stake by 14% in Q2 2026, selling an estimated $38.5K and leaving 2,802 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #1573.

Arkadios Wealth Advisors first reported a position in GMED in Q4 2019 and has held it in 7 quarters since. The position peaked at $280K in Q1 2026. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Arkadios Wealth Advisors held 2,802 shares of Globus Medical worth $221K as of Q2 2026.
  • Arkadios Wealth Advisors sold 453 Globus Medical shares in Q2 2026, an estimated $38.5K.
  • Globus Medical made up ﹤0.01% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #1573 holding.
  • Arkadios Wealth Advisors first reported a position in Globus Medical in Q4 2019 and has held it in 7 quarters since.
  • Arkadios Wealth Advisors's Globus Medical position peaked at $280K in Q1 2026.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.